chrisvoncsefalvay/vaers-outcomes huggingface dataset:
6 hours after vaccine: intense chills, 102° fever for 6 hours, muscle soreness, nausea  Day after vaccine 4/3/21:  nausea, loss of appetite, muscle soreness, blurry vision, headache 2 days after vaccine 4/4/21: headache, soreness- especially at injection site,  loss of appetite  3 days after vaccine 4/5/22: nasal congestion,  runny nose, headache, fatigue, dizziness
MD reports son recvd 3rd HIBTITER & no other vax; w/in 24 hrs devel diarrhea & became irritable; Next 3-4 days had temp to 104; Fever & diarrhea resolved but the pt remained quite irritable;
15 days later I have developed a rash and swelling to my upper right arm around the injection site. It is painful and hot and itchy. My arm feels heavy. Feels exactly how it did a day after initial injection.
Information has been received from a physician concerning a 6 year old female who on 1/25/99 was vaccinated SC with a 0.5ml dose of varicella virus vaccine live (lot number not given). On 4/7/04 the patient developed a breakthrough case of chicken pox. It was noted that the girl was exposed to someone at school with the chicken pox. The child had lesions on her back; the number of lesions was not given. It was noted that the patient recovered. Unspecified medical attention was sought. There was no product quality complaint. Follow up information received from a registered nurse indicated that the office does not remember the patient's name. No further information is expected.
several hr p/vax pt arm became red, swollen, warm to touch; redness covering most of upper arm;
Pt received 5th Anthrax vac. 04 Sep 07 in (R) arm SQ. He developed lump. Continues to have multiple lumps x 2-3. Now has developed Atropic Dermatitis at the site. It flares up-and-receds. Occasionally painful, and pruritic
not being able to catch her breath/breathing issues; lung issues like she couldn't catch her breath; body aches; Chest discomfort; got sick from it for 4 days; she is scared to take the second shot; fatigue/Tiredness; slight headache; muscles aches; This is a spontaneous report from a contactable consumer. A 66-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 11Mar2021 as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient got her first Pfizer Covid vaccine dose on 11Mar2021 and "right away" experienced  fatigue, slight headache, muscles aches on 11Mar2021. It was reported that later" she experienced not being able to catch her breath/breathing issues, lung issues like she couldn't catch her breath, body aches, chest discomfort, tiredness, got sick from it for 4 days, she was scared to take the second shot. Patient wanted know other people have experienced these side effects after the first dose. If so, did they get the second dose and did they experience the same side effects or was it worse. She asked it was more important to her to make sure the second shot is safe to take than to make a report. Outcome of the all events was unknown.  Information about the lot/batch number has been requested.
ERROR: UNUATHORIZED AGE GROUP (16 years old, Moderna EUA approved only for persons 18 years and older. Patient signed consent form with incorrect DOB indicating age greater than 16 yo).  Event discovered and forwarded for VAERS reporting. Signs and symptoms: None known Diagnosis and treatment: None known Outcome: No adverse reaction reported
Chronic skin rashes and hives started  2 weeks after I got my booster shot (Moderna). Symptoms suggest it is dermatographic urticaria.  I have no known allergies or autoimmune problems prior to this.  I didn?t get any reactions after the first two shots administered in April-May (they were also Moderna).
Got shot on Monday. Next Sunday night got unbearable jaw pain. Got Dr. appt. on Tues. Sent me for MRI and to a neurologist who checked it out as trigeminal neuralgia. Tried Gabapentin. Did not stop it. Am on Nortriptyline 25mg 1 morning and 2 at bedtime. Is some better in summer, sometimes not. Is on same side as shot was administered. 3 doctors said "No, it's a dead virus" but it is not and I feel it is from the shot.
not feeling well; food poisoning; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of unspecified age received BNT162B2 (Pfizer- BioNTech COVID 19, solution for injection, Batch/ Lot number: unknown) via an unspecified route of administration on Feb2021 as DOSE 1, SINGLE for COVID-19 immunization. The patients medical history and concomitant medications were not reported. Patient reported that she received the Covid-19 vaccine first dose two weeks ago in Feb2021, she was supposed to get her second dose of Covid-19 vaccine but she was not feeling well she had food poisoning on Feb2021. The patient had concern, she got appointment for rescheduled for her second dose. It had been 3 weeks she just needed to know if she can reschedule this because she got food poisoning and she did not feel like going to all this. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Did you/the patient previously receive a COVID-19 Vaccine?: Yes; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old male patient received BNT162b2 (BNT162B2), on 13Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 39 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "recovered", described as "Did you/the patient previously receive a COVID-19 Vaccine?: Yes"; COVID-19 (medically significant), outcome "recovered", described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Covid rebound. Tested positive and mild symptoms returned 7 days after finishing paxlovid; Negative, notes: Tested positive and mild symptoms returned 7 days after finishing paxlovid, testing negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient received anti-viral as COVID-19 treatment from 29Jun2022 to 04Jul2022. Patient had no known allergies and did not received other medication in 2 weeks. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
she's going to take the 2nd booster shot and back in march she had covi; she's going to take the 2nd booster shot and back in march she had covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: Private. The reporter is the patient.  A 70-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "she's going to take the 2nd booster shot and back in march she had covi"; COVID-19 (medically significant), outcome "unknown", described as "she's going to take the 2nd booster shot and back in march she had covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: back in march she had covid.  Clinical course: Patient stated that, she's going to take the 2nd booster shot and back in March she had Covid-19. She stated as well that she took the flu shot 2 weeks ago and she wanted to know if she can get the booster shot now.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Chest pain; left side Joint ache; Fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Dec2022 at 12:30 as dose 4 (booster), single (Lot number: GJ6742) at the age of 48 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "COVID" (unspecified if ongoing), notes: if COVID prior vaccination : Yes. Concomitant medication(s) included: INFLUENZA VACCINE taken for immunisation, on 28Dec2022 as dose 1, single; IBUPROFEN. Vaccination history included: Bnt162b2 (other vaccine same date product=Pfizer,, other vaccine same date lot number=Lot#EL3248,, other vaccine same date vaccine date=28Dec2022,, other vaccine same date dose number=1,), for COVID-19 immunization; Bnt162b2 (other vaccine same date product=Pfizer,, other vaccine same date lot number=Lot#EL3248,, other vaccine same date vaccine date=28Dec2022,, other vaccine same date dose number=2,), for COVID-19 immunization; Bnt162b2 (other vaccine same date product=Pfizer,, other vaccine same date lot number=Lot#FE3594,, other vaccine same date vaccine date=28Dec2022,, other vaccine same date dose number=3,), for COVID-19 immunization. The following information was reported: CHEST PAIN (non-serious) with onset 28Dec2022 at 23:30, outcome "recovering"; FATIGUE (non-serious) with onset 28Dec2022 at 23:30, outcome "recovering"; ARTHRALGIA (non-serious) with onset 28Dec2022 at 23:30, outcome "recovering", described as "left side Joint ache". Therapeutic measures were not taken as a result of chest pain, arthralgia, fatigue.  Additional information: The patient had chest pain, left side Joint ache (recovering as of 29Dec2022 20:40) Fatigue (recovering as of 29Dec2022 20:40). Location of injection for vaccine received within 4 weeks PRIOR: Flu - right arm. Patient received ibuprofen within 2 weeks of vaccination. No treatment for Adverse event. Prior to vaccination, patient was diagnosed with COVID-19. It was unknown that since the vaccination, the patient been tested for COVID-19.
received the first dose of the pfizer covid 19 vaccine and then got covid 7-8 days after; This is a spontaneous report from a contactable consumer (patient himself). A 70-year-old male patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on an unknown date, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date, 7 to 8 days after therapy with suspect product, experienced COVID-19 infection. It was reported that the patient and his wife received a viral cocktail and wanted to know the impact the covid virus and the viral cocktail had on the vaccine. Caller wanted to know if it is recommended to wait 90 days for the second dose. Outcome of the event was unknown.  Information about lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Chronic flare-up of Psoriasis; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PSORIASIS (Chronic flare-up of Psoriasis) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concurrent medical conditions included Psoriasis.   In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PSORIASIS (Chronic flare-up of Psoriasis). At the time of the report, PSORIASIS (Chronic flare-up of Psoriasis) had not resolved.            No concomitant medications were reported.  It was reported that patient received the two doses of Moderna covid vaccine (initial and booster in early 2021), she has been suffering from chronic flare up of psoriasis. Patient is hesitant to go get either the Moderna or Pfizer Covid BA.4/5 Booster vaccines because she's afraid her psoriasis symptoms might get even worse.   When the patient visited her general practitioner about the psoriasis, patient doctor told her that she's been seeing an increase in psoriasis in her older patients who have had the covid vaccine.   Patient was prescribed topical corticosteroid to help with the psoriasis but is still suffering.   This case was linked to US-MODERNATX, INC.-MOD-2022-689623 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-689623:MOD-2022-689623 (Other patients case)
1.5 - 2" Round, swelling, red, induration at triceps area. Varivax
Inadvertently gave JJ vaccine to a 16 year old.  No adverse reaction.  Reported to patient's physician
Patient seen for a "PPD" reading and had an 30x25mm area of induration, warmth and redness with tenderness.  CXR was ordered since it was thought this was (+) PPD.  CXR negative.  Patient subsequently seen by MD in office.  Treated with aleve, ice, rest.
Later that night she felt like she had the flu, nausea, vomiting, later that day diarrhea, and a migraine at Left temple area, sweating, hot and cold chills, after she was able to eat she felt better
This morning she felt bad; She has an autoimmune disease/ received BNT162B2; She has an autoimmune disease/ received BNT162B2; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2, via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history included autoimmune disease and has been under stress from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced felt bad this morning on an unspecified date with outcome of unknown. Caller was a therapist, behavioral specialist and works and they are all over. It's a hospital and she was in the psychiatric phase of it as a therapist. They are offering the free COVID-19 vaccine since she was working 1 on 1 with clients and some of them are not the most reputable. She has an autoimmune disease and known she should get it, but has had so many doubts and has been under stress. Took care of a brother who was blind who recently had major shoulder surgery and her 91 years old mother who lived with her. Has been stressed and noticed her autoimmune disease was flaring up. Wanted to know was it safe for her to get the vaccine. Knows she should get the vaccine because 2 of her clients had tested positive for COVID and their parents, but when she tested she was negative and her family was also negative. No further details provided. Is so afraid to get the vaccine that she canceled her appointment at the hospital. Was scheduled today to get it. They are offering it to her free since she works there. This morning she felt bad and she had been going through the stress the last month. Mentions she didn't even get the flu this year. No further details provided and does not clarify if she didn't get the flu virus or flu shot.    Information about lot/batch number has been requested.
This spontaneous report was received from a pharmacist, referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 19-OCT-2015, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB (Lot# L016427; expiration date: 13-APR-2017) (dose and route of administration were not provided). Concomitant therapies were not reported. No adverse effects reported. The pharmacist explained that the RECOMBIVAX HB doses were not involved in a previous temperature excursion and this time the temperature and time frame were: 1.4C for 22 hours 52 minutes and 8.6C for 112 hours 5 minutes. This is one of several reports from the same source (original report 1602USA004808). Additional information has been requested.
Long term side effects including fatigue, loose stool. More than six weeks.   Irresponsible to adminsiter Shingex to an individual who may have been exposed to COVID in the six months or year prior.
This spontaneous report as received from a healthcare professional refers to a patient of unknown age and gender. On 06-NOV-2014, the patient was administered with expired dose of ZOSTAVAX lot # J014851, expiration date: 21-OCT-2014 (dose and route of administration were not provided). No adverse effect has been observed or reported. Additional information has been requested.
Chills and body aches in the middle of the night. Still achey feeling a little rough today. Nothing serious. I have had similar responses from annual flu shots.
Nausea, Diarrhea, Stiff / Aching, Chills, Fever, Headache
Patient woke up and it seemed as though he was hallucinating.  He was saying that a spider was in his bed.  He then came into our room and thought there were more spiders in there.  He was asking if we saw them and panicking.  He was tachycardic and trying to point out where the spiders were in the room. He then said his hand was shimmering.  He asked if I saw the glitter which was red, green, and brown.  There were no spiders in the room nor was there any glitter on his hand.  This persisted for roughly 3 hours.  We were going to take him to the ER but he calmed down and returned to sleep under supervision.  He had recall of the spider and the glitter this morning.
Patient had received Moderna for 1st and 2nd doses and was supposed to receive Moderna for the booster dose. However, the patient was inadvertently administered Pfizer for the booster dose.
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 06-OCT-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 0.5 mL (Vls 10 SDV) (Lot # K007822, expiration date 15-AUG-2015) single dose, route and anatomical location were not provided. There was no concomitant medication provided. No adverse effects were reported. On an unknown date, the PNEUMOVAX had a temperature excursion for 72 hours, the lowest recorded temperature was 28F (-2.222 Celsius). The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported  as "Refrigerator (R)". There was no product quality complaint involved. This is one of several cases received from the same reporter. Additional information has been requested.
had anaphylaxis; This is a spontaneous report from a non-contactable other health professional. An adult female patient of unspecified age (reported as "18-24 years old") received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) at single dose, for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took flu shot and was allergic to the vaccine. The patient had anaphylaxis to her first shot on an unspecified date. The patient ended up in the hospital. Therapeutic measures were taken as a result of "anaphylaxis" included EPIPEN. The outcome of event was unknown.   No follow up attempts are possible. Information about lot/batch number cannot be requested. Sender's Comments: Based on available information, a possible contributory role of BNT162B2 vaccine can not be excluded for the reported event of anaphylaxis due to temporal relationship, and current known drug safety profile.
ARM SORENESS; inadvertently administered a dose of MMRlI on 5/29/2021, when the patient "was expecting to get a meningitis; ho is 17 years of age received her first dose of MMRlI at age 1 and the second dose at age 5; inadvertently administered a dose of MMRlI the patient "was expecting to get a meningitis vaccine", specifically MENACTRA; This spontaneous report was received from a pharmacist refers to a 17 year old female patient. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On unknown dates, at age 1 and 5 the patient received first and second dose of  measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (dose, route, vaccination site and lot# were not provided), for prophylaxis.  On 29-MAY-2021, the patient was vaccinated inadvertently administered  with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II), 0.5 milliliter, subcutaneous, lot# T00723, expiration date 27-FEB-2022, for prophylaxis when the patient was expecting to get a meningitis vaccine, specifically  meningococcal vaccine a/c/y/w conj (dip tox)(MENACTRA).  On the same date, the patient experienced some arm soreness (pain in extremity).     At the time of reporting, the reporter recovered from pain in extremity approximately in 2021.   The reporter did not provide a causality assessment betweenpain in extremity and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live(M-M-R II).
Miscarriage, became pregnant after receiving the vaccine. Final dose on February, pregnant in May, loss of pregnancy in July.
This non-valid, spontaneous report was received from a registered nurse, referring to an unspecified number of patients of unknown age and gender. No information was provided regarding the patients' medical history, previous drug reactions, allergies, concurrent medical conditions or concomitant medications. On unknown dates, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB lot number N034005 (expiration date 31-JAN-2020) and lot number reported as "N021920" (expiration date 07-FEB-2020) for prophylaxis (doses, routes and anatomical locations of administration were not reported). Additionally, the patients were vaccinated with ROTATEQ by oral route, lot number N005078 (expiration dates 22-NOV-2018 and 04-OCT-2018) for prophylaxis (doses were unknown), GARDASIL 9 lot number N020352 (expiration date 10-APR-2020) for prophylaxis (doses, routes and anatomical locations of administration were not provided) and M-M-R II for prophylaxis (dose numbers, routes and anatomical locations of administration were not provided; lot numbers N010496 [expiration date 31-MAR-2019], N014485 [expiration date 10-MAY-2019], and N023149 [expiration date 24-AUG-2019]). The vaccines were reconstituted with sterile diluent which was reported to be properly stored. The doses of all vaccines were exposed to a temperature excursion below 32 degrees Fahrenheit (F) (also reported as 31F) during a time frame of 15 days, which was detected by the Digital Data Logger. There was no prior temperature excursion and no adverse effects were reported. Follow-up information was received from the nurse on 17-DEC-2018. The reporter provided patients' demographics which made the case valid. This report refers to a 15-month-old patient of unknown gender. On 25-JUN-2018, the patient was vaccinated with an improperly stored dose of VARIVAX lot number N034554 (expiration date 05-DEC-2019). This is one of multiple reports received from the same reporter. Sender's Comments: US-009507513-1812USA010296.
Patient's mom calling with son complaining of bad headache, stomach ache, chills, dizzy, neck pain.
Received Flu Mist vaccine in flu shot clinic (known what time he received it).  Mom states that he developed abdominal pain and then frequent nonbloody, nonbilious diarrhea 5-10 times per day. Maybe some congestion and cough also seen after flu mist.
Vaccine administered had a low temperature excursion and it was invalid. This was discovered after the vaccine was administered. Patient has not reported any events.
Fever of 103, chills, cough, sore throat, body aches. Had tests done, chest x-ray. Missed 2 weeks of work.